Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MRTX - Mirati: Can Adagrasib Beat Amgen's Lumakras?

MRTX - Mirati: Can Adagrasib Beat Amgen's Lumakras?

Mirati Therapeutics Inc.
  • Mirati has a PDUFA on December 14.
  • Lumakras is already approved conditionally, with confirmatory data this year.
  • While adagrasib is marginally better in NSCLC, the real fight is in CRC and pancreatic cancer.

For further details see:

Mirati: Can Adagrasib Beat Amgen's Lumakras?
Stock Information
Company Name: Mirati Therapeutics Inc.
Stock Symbol: MRTX
Market: NASDAQ
Website: mirati.com
Menu
MRTX MRTX Quote MRTX Short MRTX News MRTX Articles MRTX Message Board
Get MRTX Alerts

News, Short Squeeze, Breakout and More Instantly...